Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2004 1
2007 1
2012 1
2014 1
2015 4
2016 2
2017 3
2018 7
2019 5
2020 10
2021 4
2022 4
2023 9
2024 10
2025 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

62 results

Results by year

Filters applied: . Clear all
Page 1
Role of genetics and epigenetics in Graves' orbitopathy.
Marinò M, Rotondo Dottore G, Menconi F, Comi S, Cosentino G, Rocchi R, Latrofa F, Figus M, Santini F. Marinò M, et al. Among authors: comi s. Eur Thyroid J. 2024 Nov 6;13(6):e240179. doi: 10.1530/ETJ-24-0179. Print 2024 Dec 1. Eur Thyroid J. 2024. PMID: 39378053 Free PMC article. Review.
IgG4 serum levels in Graves' orbitopathy.
Comi S, Lanzolla G, Cosentino G, Maglionico MN, Posarelli C, Menconi F, Santini F, Elisei R, Marinò M. Comi S, et al. J Endocrinol Invest. 2024 Jul;47(7):1711-1717. doi: 10.1007/s40618-023-02265-3. Epub 2023 Dec 21. J Endocrinol Invest. 2024. PMID: 38127192
Statins in Graves Orbitopathy: A New Therapeutic Tool.
Lanzolla G, Comi S, Cosentino G, Pakdel F, Marinò M. Lanzolla G, et al. Among authors: comi s. Ophthalmic Plast Reconstr Surg. 2023 Dec 1;39(6S):S29-S39. doi: 10.1097/IOP.0000000000002525. Epub 2023 Dec 4. Ophthalmic Plast Reconstr Surg. 2023. PMID: 38054983 Review.
In vivo and in vitro evidence for a protective role of autoantibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves' orbitopathy.
Lanzolla G, Rotondo Dottore G, Comi S, Cosentino G, Ciampa DA, Sabini E, Menconi F, Maglionico MN, Posarelli C, Rocchi R, Latrofa F, Figus M, Santini F, Marinò M. Lanzolla G, et al. Among authors: comi s. Endocrine. 2025 Jul;89(1):137-142. doi: 10.1007/s12020-025-04219-6. Epub 2025 Mar 29. Endocrine. 2025. PMID: 40156685
Absence of a relationship between vitamin D and Graves' orbitopathy.
Lanzolla G, Di Matteo L, Comi S, Cosentino G, Menconi F, Maglionico MN, Posarelli C, Figus M, Marinò M. Lanzolla G, et al. Among authors: comi s. J Endocrinol Invest. 2023 Aug;46(8):1717-1721. doi: 10.1007/s40618-023-02017-3. Epub 2023 Jan 25. J Endocrinol Invest. 2023. PMID: 36696067 No abstract available.
Long-term outcome of Graves' orbitopathy following treatment with sirolimus.
Comi S, Cosentino G, Lanzolla G, Menconi F, Maglionico MN, Posarelli C, Latrofa F, Rocchi R, Figus M, Santini F, Marinò M. Comi S, et al. J Endocrinol Invest. 2025 Mar;48(3):607-618. doi: 10.1007/s40618-024-02470-8. Epub 2024 Oct 7. J Endocrinol Invest. 2025. PMID: 39373962 Free PMC article.
Sirolimus for the treatment of Graves' orbitopathy.
Comi S, Sabini E, Cosentino G, Santini F, Marinò M. Comi S, et al. Thyroid Res. 2025 Dec 2;18(1):55. doi: 10.1186/s13044-025-00273-4. Thyroid Res. 2025. PMID: 41327233 Free PMC article. Review.
Targeting specific brain districts for advanced nanotherapies: A review from the perspective of precision nanomedicine.
Sierri G, Patrucco M, Ferrario D, Renda A, Comi S, Ciprandi M, Fontanini V, Sica FS, Sesana S, Costa Verdugo M, Kravicz M, Salassa L, Busnelli M, Re F. Sierri G, et al. Among authors: comi s. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024 Sep-Oct;16(5):e1991. doi: 10.1002/wnan.1991. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024. PMID: 39251878 Free PMC article. Review.
62 results